{"id":"https://openalex.org/W4283810334","doi":"https://doi.org/10.1136/bmjresp-2022-001310","title":"Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis","display_name":"Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-01","ids":{"openalex":"https://openalex.org/W4283810334","doi":"https://doi.org/10.1136/bmjresp-2022-001310","pmid":"https://pubmed.ncbi.nlm.nih.gov/35787522","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9255390"},"language":"en","primary_location":{"id":"doi:10.1136/bmjresp-2022-001310","doi":"https://doi.org/10.1136/bmjresp-2022-001310","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjresp-2022-001310","pdf_url":"https://bmjopenrespres.bmj.com/content/bmjresp/9/1/e001310.full.pdf","source":{"id":"https://openalex.org/S2736820664","display_name":"BMJ Open Respiratory Research","issn_l":"2052-4439","issn":["2052-4439"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respiratory Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4283810334"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmjopenrespres.bmj.com/content/bmjresp/9/1/e001310.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052485494","display_name":"Steven D. Nathan","orcid":"https://orcid.org/0000-0002-6270-1617","observed_orcids":["https://orcid.org/0000-0002-6270-1617"]},"institutions":[{"id":"https://openalex.org/I2800468613","display_name":"Inova Fairfax Hospital","ror":"https://ror.org/0212h5y77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498","https://openalex.org/I2800468613"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Steven D Nathan","raw_affiliation_strings":["Lung Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lung Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia, USA","institution_ids":["https://openalex.org/I2800468613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078455402","display_name":"J\u00fcrgen Behr","orcid":"https://orcid.org/0000-0002-9151-4829","observed_orcids":["https://orcid.org/0000-0002-9151-4829"]},"institutions":[{"id":"https://openalex.org/I4210129183","display_name":"German Center for Lung Research","ror":"https://ror.org/03dx11k66","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210129183","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jurgen Behr","raw_affiliation_strings":["Department of Medicine V, University Hospital, Ludwig Maximilians University Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine V, University Hospital, Ludwig Maximilians University Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), Munich, Germany","institution_ids":["https://openalex.org/I4210129183","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014703126","display_name":"Vincent Cottin","orcid":"https://orcid.org/0000-0002-5591-0955","observed_orcids":["https://orcid.org/0000-0002-5591-0955"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210136143","display_name":"H\u00f4pital Louis Pradel","ror":"https://ror.org/0396v4y86","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210136143"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vincent Cottin","raw_affiliation_strings":["Service de pneumologie, Hospices Civils de Lyon, H\u00f4pital Louis Pradel, National des maladies pulmonaires ra, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de pneumologie, Hospices Civils de Lyon, H\u00f4pital Louis Pradel, National des maladies pulmonaires ra, Lyon, France","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4210136143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030667668","display_name":"LISA H. LANCASTER","orcid":"https://orcid.org/0000-0001-8465-7357","observed_orcids":["https://orcid.org/0000-0001-8465-7357"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa Lancaster","raw_affiliation_strings":["Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060885607","display_name":"Peter Smith","orcid":"https://orcid.org/0000-0002-2051-7774","observed_orcids":["https://orcid.org/0000-0002-2051-7774"]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Smith","raw_affiliation_strings":["Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107073876","display_name":"CQ Deng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"CQ Deng","raw_affiliation_strings":["Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Natalie Pearce","orcid":"https://orcid.org/0000-0002-0545-6432","observed_orcids":["https://orcid.org/0000-0002-0545-6432"]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Natalie Pearce","raw_affiliation_strings":["Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0002-0545-6432","affiliations":[{"raw_affiliation_string":"Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113232390","display_name":"Heidi Bell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heidi Bell","raw_affiliation_strings":["Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104667192","display_name":"Leigh Peterson","orcid":"https://orcid.org/0009-0007-1218-5435","observed_orcids":["https://orcid.org/0009-0007-1218-5435"]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leigh Peterson","raw_affiliation_strings":["Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development, United Therapeutics Corp Research and Development, Research Triangle Park, North Carolina, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010115182","display_name":"Kevin R. Flaherty","orcid":"https://orcid.org/0000-0001-7686-0291","observed_orcids":["https://orcid.org/0000-0001-7686-0291"]},"institutions":[{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kevin R Flaherty","raw_affiliation_strings":["Division of Pulmonary and Critical Care Medicine, University of Michigan Hospital, Ann Arbor, Michigan, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary and Critical Care Medicine, University of Michigan Hospital, Ann Arbor, Michigan, USA","institution_ids":["https://openalex.org/I4210114445"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5052485494"],"corresponding_institution_ids":["https://openalex.org/I2800468613"],"apc_list":{"value":1700,"currency":"GBP","value_usd":2085},"apc_paid":{"value":1700,"currency":"GBP","value_usd":2085},"fwci":8.5697,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.98781883,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"9","issue":"1","first_page":"e001310","last_page":"e001310"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/inhaled-treprostinil","display_name":"inhaled treprostinil","score":0.9900000095367432},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.8519999980926514},{"id":"https://openalex.org/keywords/forced-vital-capacity","display_name":"forced vital capacity","score":0.8569999933242798},{"id":"https://openalex.org/keywords/respiratory-hospitalization","display_name":"respiratory hospitalization","score":0.5879999995231628},{"id":"https://openalex.org/keywords/king-s-brief-interstitial-lung-disease-questionnaire","display_name":"King's Brief Interstitial Lung Disease questionnaire","score":0.8199999928474426},{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":0.7400000095367432},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pulmonary-hypertension","display_name":"pulmonary hypertension","score":0.375}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9347237348556519},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.8393577933311462},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.8178050518035889},{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.6982547044754028},{"id":"https://openalex.org/C2776432619","wikidata":"https://www.wikidata.org/wiki/Q3495231","display_name":"Treprostinil","level":3,"score":0.6212359666824341},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.5894683003425598},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5351216793060303},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5229609608650208},{"id":"https://openalex.org/C73751289","wikidata":"https://www.wikidata.org/wiki/Q2985397","display_name":"Data monitoring committee","level":3,"score":0.4902549088001251},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.48951542377471924},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.48864609003067017},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4813893139362335},{"id":"https://openalex.org/C55520419","wikidata":"https://www.wikidata.org/wiki/Q660995","display_name":"Vital capacity","level":5,"score":0.4799692630767822},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.47263428568840027},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4170333743095398},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.40416407585144043},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.25628137588500977},{"id":"https://openalex.org/C165637977","wikidata":"https://www.wikidata.org/wiki/Q11067835","display_name":"Diffusing capacity","level":4,"score":0.15304362773895264},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12779226899147034},{"id":"https://openalex.org/C3018587741","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung function","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054990","descriptor_name":"Idiopathic Pulmonary Fibrosis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D054990","descriptor_name":"Idiopathic Pulmonary Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1136/bmjresp-2022-001310","doi":"https://doi.org/10.1136/bmjresp-2022-001310","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjresp-2022-001310","pdf_url":"https://bmjopenrespres.bmj.com/content/bmjresp/9/1/e001310.full.pdf","source":{"id":"https://openalex.org/S2736820664","display_name":"BMJ Open Respiratory Research","issn_l":"2052-4439","issn":["2052-4439"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respiratory Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9255390","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9255390/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respir Res","raw_type":"Text"},{"id":"pmid:35787522","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35787522","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ open respiratory research","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:e8146d59c30347a497ae053b3dc19329","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e8146d59c30347a497ae053b3dc19329","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)","raw_type":"article"},{"id":"pmh:oai:epub.ub.uni-muenchen.de:107221","doi":null,"is_oa":true,"landing_page_url":"http://nbn-resolving.de/urn:nbn:de:bvb:19-epub-107221-6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401845","display_name":"Open access LMU (Ludwid Maxmilian's Universitat Munchen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8204097","host_organization_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","host_organization_lineage":["https://openalex.org/I8204097"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open Respiratory Research","raw_type":"doc-type:article"}],"best_oa_location":{"id":"doi:10.1136/bmjresp-2022-001310","doi":"https://doi.org/10.1136/bmjresp-2022-001310","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjresp-2022-001310","pdf_url":"https://bmjopenrespres.bmj.com/content/bmjresp/9/1/e001310.full.pdf","source":{"id":"https://openalex.org/S2736820664","display_name":"BMJ Open Respiratory Research","issn_l":"2052-4439","issn":["2052-4439"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respiratory Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309555","display_name":"United Therapeutics Corporation","ror":"https://ror.org/03wgxjb31"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283810334.pdf","grobid_xml":"https://content.openalex.org/works/W4283810334.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W13250750","https://openalex.org/W1954728404","https://openalex.org/W2083977896","https://openalex.org/W2125749357","https://openalex.org/W2560929115","https://openalex.org/W2783225214","https://openalex.org/W2889197569","https://openalex.org/W2903654157","https://openalex.org/W2906077632","https://openalex.org/W2976822390","https://openalex.org/W3021543659","https://openalex.org/W3119793303","https://openalex.org/W3157928811","https://openalex.org/W3176751071","https://openalex.org/W4299622773"],"related_works":["https://openalex.org/W4312443231","https://openalex.org/W4410268266","https://openalex.org/W4416635694","https://openalex.org/W7165575394","https://openalex.org/W7165550526","https://openalex.org/W7165529523","https://openalex.org/W7161607192","https://openalex.org/W7135087781","https://openalex.org/W7167901617","https://openalex.org/W4410268652"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Idiopathic":[1],"pulmonary":[2,50],"fibrosis":[3],"(IPF)":[4],"greatly":[5],"impacts":[6],"quality":[7],"of":[8,33,63,73,82,104,119,145,161,228],"life":[9],"and":[10,30,170,190,231,235],"eventually":[11],"leads":[12],"to":[13,53,140,157,201],"premature":[14],"death":[15],"from":[16,41],"respiratory":[17,147],"failure.":[18],"Inhaled":[19],"treprostinil":[20],"was":[21],"associated":[22],"with":[23,48,60,112,216],"improvements":[24],"in":[25,37,46,70,130,152,166,172,214,242],"forced":[26],"vital":[27],"capacity":[28],"(FVC)":[29],"reduced":[31],"exacerbations":[32],"underlying":[34],"lung":[35,55],"disease":[36],"post":[38],"hoc":[39],"analyses":[40],"a":[42,102,243],"phase":[43,89],"3":[44,90],"study":[45],"patients":[47],"precapillary":[49],"hypertension":[51],"due":[52],"interstitial":[54],"disease.":[56],"These":[57],"results,":[58],"combined":[59],"preclinical":[61],"evidence":[62],"treprostinil's":[64],"antifibrotic":[65],"activity,":[66],"support":[67],"its":[68],"investigation":[69],"the":[71,173,217],"treatment":[72],"IPF.":[74],"METHODS":[75],"AND":[76,208],"ANALYSIS:":[77],"The":[78,125],"TETON":[79],"programme":[80],"consists":[81],"two":[83],"replicate,":[84],"52-week,":[85],"randomised,":[86],"double-blind":[87],"placebo-controlled,":[88],"studies,":[91],"each":[92],"enrolling":[93],"396":[94],"subjects":[95,99],"(NCT04708782,":[96],"NCT05255991).":[97],"Eligible":[98],"must":[100],"have":[101],"diagnosis":[103],"IPF":[105],"confirmed":[106],"by":[107],"central":[108],"imaging":[109],"review,":[110],"along":[111],"an":[113,203],"FVC":[114,132,169],"\u226545%.":[115],"Stable":[116],"background":[117],"use":[118],"pirfenidone":[120],"or":[121,149],"nintedanib":[122],"is":[123,128],"allowed.":[124],"primary":[126],"endpoint":[127],"change":[129,165,171],"absolute":[131],"at":[133,180],"week":[134,181,196],"52.":[135,182],"Secondary":[136],"endpoints":[137],"include":[138,185],"time":[139,156],"clinical":[141],"worsening":[142],"(first":[143],"event":[144],"death,":[146],"hospitalisation":[148],"\u226510%":[150],"decline":[151],"%":[153,167],"predicted":[154,168],"FVC),":[155],"first":[158],"acute":[159],"exacerbation":[160],"IPF,":[162],"overall":[163],"survival,":[164],"King's":[174],"Brief":[175],"Interstitial":[176],"Lung":[177],"Disease":[178],"Questionnaire":[179],"Safety":[183],"parameters":[184],"adverse":[186],"events,":[187],"hospitalisations,":[188],"oxygenation":[189],"laboratory":[191],"parameters.":[192],"Patients":[193],"who":[194],"complete":[195],"52":[197],"will":[198,211,239],"be":[199,212,240],"eligible":[200],"enter":[202],"open-label":[204],"extension":[205],"study.":[206],"ETHICS":[207],"DISSEMINATION:":[209],"Studies":[210],"conducted":[213],"accordance":[215],"International":[218],"Conference":[219],"on":[220],"Harmonisation":[221],"Guideline":[222],"for":[223],"Good":[224],"Clinical":[225],"Practice,":[226],"Declaration":[227],"Helsinki":[229],"principles,":[230],"local":[232],"regulatory,":[233],"ethical":[234],"legal":[236],"requirements.":[237],"Results":[238],"published":[241],"peer-reviewed":[244],"publication.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4283810334","counts_by_year":[{"year":2026,"cited_by_count":24},{"year":2025,"cited_by_count":23},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":15}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-07-06T00:00:00"}
